Implantable drug-delivery devices, and apparatus and methods for refilling the devices

US9901687B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9901687-B2
Application numberUS-201313868649-A
CountryUS
Kind codeB2
Filing dateApr 23, 2013
Priority dateJan 3, 2008
Publication dateFeb 27, 2018
Grant dateFeb 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In various embodiments, a needle is employed in refilling drug-delivery devices.

First claim

Opening claim text (preview).

What is claimed is: 1. An implantable drug-delivery device, comprising: a drug reservoir; a needle entry port comprising a throat for receiving a refill needle therethrough, the throat opening into a vestibule that is in fluid communication with the drug reservoir; and a visualization ring surrounding the needle entry port, the visualization ring being visible through ocular tissue so as to visually indicate a position of the needle entry port, wherein the vestibule (i) is wider than the throat, and (ii) comprises a stop on a wall opposite the throat for halting progress of a needle into the vestibule through the throat. 2. The implantable drug-delivery device of claim 1 , wherein the stop is sized so as to halt the progress of a needle comprising an exit port at a point at which the exit port is in fluid communication with the vestibule. 3. The implantable drug-delivery device of claim 1 , wherein a top surface of the stop is cupshaped. 4. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of a biocompatible material. 5. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of at least one of a metal, a plastic, or a composite material. 6. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of a material selected from the group consisting of PDMS, polyimide, polypropylene, PEEK, polycarbonate, an acetyl film, polyoxymethylene plastic, gold, stainless steel, nickel, and chrome. 7. The implantable drug-delivery device of claim 1 further comprising a check valve located between the vestibule and the drug reservoir. 8. The implantable drug-delivery device of claim 1 , wherein the needle entry port further comprises a self-sealing material. 9. The implantable drug-delivery device of claim 1 , wherein the visualization ring is constructed of a biocompatible material. 10. The implantable drug-delivery device of claim 1 , wherein the visualization ring is constructed of a material that withstands penetration by the refill needle. 11. The implantable drug-delivery device of claim 1 , wherein the visualization ring is visible through a patient's conjunctiva. 12. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a light emitting diode. 13. The implantable drug-delivery device of claim 1 further comprising a light emitting diode and optical fiber for conducting light from the light emitting diode to and around the visualization ring. 14. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a material that enhances surface echogenicity and acoustic shadowing. 15. The implantable drug-delivery device of claim 1 further comprising electronics to move or vibrate the visualization ring. 16. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a magnetic material. 17. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a fluorescent pigment. 18. The implantable drug-delivery device of claim 17 , wherein the fluorescent pigment is selected from the group consisting of a luminescent aerogel, a nanoparticle, a phthalocyanine pigment, fluorescein isothiocyanate, rhodamine, coumarin, cyanine, an Alexa Fluor, a DyLight Fluor, a quantum dot, a green fluorescent protein, and a luciferin.

Assignees

Inventors

Classifications

  • by visual feedback · CPC title

  • Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body} · CPC title

  • having means for controlling depth of insertion · CPC title

  • by tactile feedback · CPC title

  • A61F9/0017Primary

    implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9901687B2 cover?
In various embodiments, a needle is employed in refilling drug-delivery devices.
Who is the assignee on this patent?
Meng Ellis Fan Chuin, Humayun Mark S, Lo Mann Ronalee, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61F9/0017. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).